[go: up one dir, main page]

DK1233784T3 - Præparater og fremgangsmåder til stabilisering af biologiske molekyler efter lyofilisering - Google Patents

Præparater og fremgangsmåder til stabilisering af biologiske molekyler efter lyofilisering

Info

Publication number
DK1233784T3
DK1233784T3 DK00992589T DK00992589T DK1233784T3 DK 1233784 T3 DK1233784 T3 DK 1233784T3 DK 00992589 T DK00992589 T DK 00992589T DK 00992589 T DK00992589 T DK 00992589T DK 1233784 T3 DK1233784 T3 DK 1233784T3
Authority
DK
Denmark
Prior art keywords
biological molecules
methods
lyophilization
preparations
stabilizing biological
Prior art date
Application number
DK00992589T
Other languages
Danish (da)
English (en)
Inventor
Irina Esikova
Sidney Wolfe
James Thomson
Hora Maninder
Original Assignee
Novartis Vaccines & Diagnostic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22611688&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1233784(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Vaccines & Diagnostic filed Critical Novartis Vaccines & Diagnostic
Application granted granted Critical
Publication of DK1233784T3 publication Critical patent/DK1233784T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/095Neisseria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6037Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK00992589T 1999-12-02 2000-12-01 Præparater og fremgangsmåder til stabilisering af biologiske molekyler efter lyofilisering DK1233784T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16848699P 1999-12-02 1999-12-02
PCT/US2000/042484 WO2001041800A2 (en) 1999-12-02 2000-12-01 Compositions and methods for stabilizing biological molecules upon lyophilization

Publications (1)

Publication Number Publication Date
DK1233784T3 true DK1233784T3 (da) 2008-09-01

Family

ID=22611688

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00992589T DK1233784T3 (da) 1999-12-02 2000-12-01 Præparater og fremgangsmåder til stabilisering af biologiske molekyler efter lyofilisering

Country Status (10)

Country Link
EP (2) EP1233784B1 (ja)
JP (2) JP4948731B2 (ja)
AT (1) ATE400296T1 (ja)
CA (1) CA2393298C (ja)
CY (1) CY1108382T1 (ja)
DE (1) DE60039450D1 (ja)
DK (1) DK1233784T3 (ja)
ES (1) ES2307553T3 (ja)
PT (1) PT1233784E (ja)
WO (1) WO2001041800A2 (ja)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4948731B2 (ja) 1999-12-02 2012-06-06 ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド 凍結乾燥の際に生物学的分子を安定化するための組成物および方法
KR100947757B1 (ko) 2001-01-23 2010-03-18 아벤티스 파스퇴르 다가 수막구균 폴리사카라이드―단백질 접합체 백신
GB0115176D0 (en) * 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
GB0118249D0 (en) 2001-07-26 2001-09-19 Chiron Spa Histidine vaccines
CA2452720C (en) * 2001-07-26 2012-04-17 Chiron S.R.L. Vaccines comprising aluminium adjuvants and histidine
MX339524B (es) 2001-10-11 2016-05-30 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
AU2003287980B2 (en) 2002-11-01 2009-06-25 Glaxosmithkline Biologicals S.A. Drying process
ES2383175T3 (es) 2003-01-30 2012-06-18 Novartis Ag Vacunas inyectables contra múltiples serogrupos de meningococos
US20070031501A1 (en) * 2003-08-05 2007-02-08 Andries Van Es Use of recombinant or synthetic gelatin-like proteins as stabiliser in lyophilized pharmaceutical compositions
JP2007509164A (ja) 2003-10-23 2007-04-12 カイロン コーポレイション 安定化組成物
GB0404586D0 (en) * 2004-03-01 2004-04-07 Britannia Pharmaceuticals Ltd Improvements in or relating to organic materials
GB0409745D0 (en) 2004-04-30 2004-06-09 Chiron Srl Compositions including unconjugated carrier proteins
BRPI0612655B1 (pt) 2005-06-27 2021-06-15 Pfizer Ireland Pharmaceuticals Composição imunogênica
PL2004225T3 (pl) 2006-03-22 2012-09-28 Novartis Ag Schematy immunizacji koniugatami meningokokowymi
US10828361B2 (en) 2006-03-22 2020-11-10 Glaxosmithkline Biologicals Sa Regimens for immunisation with meningococcal conjugates
TW200806315A (en) * 2006-04-26 2008-02-01 Wyeth Corp Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
TW201009337A (en) * 2008-05-30 2010-03-01 Intervet Int Bv Analytical method to monitor vaccine potency and stability
AU2009314311B2 (en) 2008-10-29 2013-01-10 Ablynx N.V. Methods for purification of single domain antigen binding molecules
AR073997A1 (es) 2008-10-29 2010-12-15 Wyeth Corp Formulaciones de moleculas de union a antigeno de dominio unico. metodo. kit
PL3170508T3 (pl) 2010-06-04 2020-04-30 Wyeth Llc Preparaty szczepionek
ES2994878T3 (en) 2010-08-23 2025-02-03 Wyeth Llc Stable formulations of neisseria meningitidis rlp2086 antigens
KR101584871B1 (ko) 2010-09-10 2016-01-22 와이어쓰 엘엘씨 네이세리아 메닝기티디스 orf2086 항원의 비-지질화된 변이체
CA2828844C (en) 2011-03-02 2020-07-14 Novartis Ag Combination vaccines with lower doses of antigen and/or adjuvant
JP6048845B2 (ja) * 2011-06-01 2016-12-21 シャモン ユニヴァーシティー ジフテリア毒素の無毒性突然変異体crm197又はその断片を含む融合タンパク質
WO2013092985A1 (en) * 2011-12-23 2013-06-27 Novartis Ag Stable compositions for immunising against staphylococcus aureus
IN2012MU00206A (ja) 2012-01-20 2013-08-09
EP2822584A1 (en) 2012-03-08 2015-01-14 Novartis AG Combination vaccines with tlr4 agonists
SA115360586B1 (ar) 2012-03-09 2017-04-12 فايزر انك تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
BR122016004924A2 (pt) 2012-03-09 2019-07-30 Pfizer Inc. Polipeptídeo isolado e composições imunogênicas compreendendo os mesmos
BR112014030025A2 (pt) * 2012-05-30 2017-06-27 Brigham & Womens Hospital Inc composições de polissacarídeo e métodos de uso
JP2015527310A (ja) * 2012-06-28 2015-09-17 アンサン バイオファーマ, インコーポレイテッドAnsun Biopharma, Inc. 下気道および中枢気道への送達用微粒子製剤ならびに製造方法
CN104487086B (zh) * 2012-07-07 2019-08-30 巴拉特生物技术国际有限公司 无动物源的不含酒精的疫苗组合物及其制备方法
CA2882619A1 (en) 2012-09-06 2014-03-13 Novartis Ag Combination vaccines with serogroup b meningococcus and d/t/p
KR20150073943A (ko) 2012-10-03 2015-07-01 글락소스미스클라인 바이오로지칼즈 에스.에이. 면역원성 조성물
BR112015014250A2 (pt) 2012-12-18 2017-07-11 Glaxosmithkline Biologicals Sa método para imunizar um bebê, vacina de combinação e, kit
EP2964665B1 (en) 2013-03-08 2018-08-01 Pfizer Inc Immunogenic fusion polypeptides
CA2923129C (en) 2013-09-08 2020-06-09 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
WO2016132294A1 (en) 2015-02-19 2016-08-25 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
US10183070B2 (en) 2017-01-31 2019-01-22 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
CA3117867A1 (en) 2018-11-06 2020-05-14 Glaxosmithkline Biologicals Sa Immunogenic compositions
US12397014B2 (en) 2019-02-05 2025-08-26 The Brigham And Women's Hospital, Inc. Polysaccharide compositions for use in treating filariasis
WO2021059181A1 (en) 2019-09-27 2021-04-01 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
GB202208089D0 (en) * 2022-06-01 2022-07-13 Glaxosmithkline Biologicals Sa Immunogenic composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9422096D0 (en) * 1994-11-02 1994-12-21 Biocine Spa Combined meningitis vaccine
CN102416176A (zh) * 1995-07-27 2012-04-18 基因技术股份有限公司 稳定等渗的冻干蛋白质制剂
JP4948731B2 (ja) 1999-12-02 2012-06-06 ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド 凍結乾燥の際に生物学的分子を安定化するための組成物および方法

Also Published As

Publication number Publication date
JP2003516361A (ja) 2003-05-13
CY1108382T1 (el) 2014-02-12
WO2001041800A2 (en) 2001-06-14
DE60039450D1 (de) 2008-08-21
EP2292263A3 (en) 2011-07-27
WO2001041800A3 (en) 2002-01-03
EP2292263A2 (en) 2011-03-09
PT1233784E (pt) 2008-11-03
JP2011137047A (ja) 2011-07-14
WO2001041800A9 (en) 2002-08-01
ATE400296T1 (de) 2008-07-15
ES2307553T3 (es) 2008-12-01
JP4948731B2 (ja) 2012-06-06
EP1233784A2 (en) 2002-08-28
CA2393298C (en) 2011-02-01
CA2393298A1 (en) 2001-06-14
EP1233784B1 (en) 2008-07-09

Similar Documents

Publication Publication Date Title
DK1233784T3 (da) Præparater og fremgangsmåder til stabilisering af biologiske molekyler efter lyofilisering
NO20025450D0 (no) Ny farmasöytisk sammensetning
DK1117440T3 (da) Farmaceutiske sammensætninger indeholdende paclitaxel
LU92060I2 (fr) Interféron beta-1a
DK1887016T3 (da) Fragmenter af humant choriongonadotropin (HCG) som immunoregulator
CY1113312T1 (el) Κυκλικοι αναστολεις κινασης τυροσινης πρωτεϊνων
DK0535091T3 (da) Knogleinducerende farmaceutiske formuleringer
PT1347971E (pt) Inibidores tiazolilicos de tirosina-cinases da familia tec
EA199901031A1 (ru) Производные бензимидазола
EA200000789A1 (ru) N-[(замещенное пятичленное ди- или триазадиненасыщенное кольцо) карбонил] гуанидиновые производные для лечения ишемии
MY141641A (en) Compositions comprising viruses and methods for concentrating virus preparations
CY1110914T1 (el) Δικυκλο-πυραζολες δραστικες ως αναστολεις kinασων, διεργασια για την παρασκευη τους και φαρμακευτικες συνθεσεις που τις περιλαμβανουν
FI942186A0 (fi) Sytokiinituotantoa indusoivat uretaanit ja ureat
DK0921785T3 (da) Kombination af syreproteaseenzymer og sure puffere og anvendelser deraf
DE60019458D1 (de) Stabilisierendes verdünnungsmittel für polypeptide und antigene
AU2001277961A1 (en) Compositions comprising heat shock proteins or alpha(2)macroglobulin, antigenic molecules and saponins, and methods of use thereof
TR200200821T2 (tr) 5-Beta-sapojenin ve pseudosapojenin türevleri ve bunların bunama tedavisinde kullanımı.
ES2011232A4 (es) Compuestos farmaceuticos en piroxicam en soluciones acuosas y proceso para su preparacion
DK1219301T3 (da) Vacciner, som indeholder hybridpolypeptider, der består af mindst to forskellige allergene proteiner
EA200001164A1 (ru) КОМБИНАЦИИ ИНГИБИТОРОВ ПРОТЕИН ФАРНЕЗИЛТРАНСФЕРАЗЫ И HMG KoA РЕДУКТАЗЫ И ИХ ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАКА
ATE341339T1 (de) Zusammensetzungen von rekombinanten papillomavirus vakzinen
BR0104082A (pt) Processo de tratamento conveniente para a deformação e/ou conformação, e isto de modo permanente, dos materiais queratìnicos e, particulamente, dos cabelos, composição cosmética redutora, e kit para tratamento
NO20015398D0 (no) Endoparasitticidisk synergistisk kombinasjon inneholdende cykliske depsipeptider og piperaziner
DE60024977D1 (de) Klonierung und expression von haemophilus somnus transferrin-bindenden proteinen
DK1219299T3 (da) Allergivacciner og fremstilling deraf